Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 December 2005, Vol. 106, No. 13, pp. 4412-4413.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

CORRESPONDENCE

To the editor:

T-cell grit: large clonal expansions of virus-specific CD8+ T cells can dominate in the peripheral circulation for at least 18 years

Epstein-Barr virus (EBV) establishes a latent, life-long infection in more than 95% of the human adult population. Antigen-specific, cytolytic T lymphocytes (CTLs) are thought to be of central importance in controlling EBV in both primary and latent infection states. While a good deal is known about the CTL dynamics during primary infection and convalescence,1-4 little is known about the CTL repertoire during the decades of infection after first contact. For example, do CTL clones persist indefinitely throughout an individual's lifetime or do new naive T-cell expansions emerge to help refresh the repertoire? We addressed this question by investigating the CTL dynamics toward immunodominant EBV epitopes up to 18 years apart, which is, to our knowledge, the longest follow-up study of T-cell responses conducted in humans.

The CTL response toward a latent HLA B*0801-binding EBV epitope, FLRGRAYGL (FLR), has been described previously and was found to comprise large expansions of T cells bearing identical T-cell receptor (TcR) amino acid sequences in unrelated, B*0801+ individuals.5-8 In this follow-up study we investigated the FLR-specific T-cell repertoire of donor 1 using seven T-cell clones generated in 1987 and a pool of ex vivo, pentamer-sorted lymphocytes from 2005 (Figure 1A). Fifty-five TcR sequences derived from both time points revealed only a single TRBV7-8/TRAV26 clonal expansion, identical to the DNA level.

The CTL response toward another latent HLA B*4405-binding EBV epitope, EENLLDFVRF (EEN), has also been described previously,10 but no tetramer or TcR sequence information is currently available. As a result, we sequenced 91 TcRs from the EEN-specific CTL repertoire from donor 2 using a pool of ex vivo, tetramer-sorted T cells from cryogenically stored lymphocytes from 1994 and 2005 (Figure 1B). Like the FLR-specific repertoire in donor 1, the donor 2 EEN-specific repertoire consisted of a single, nucleotide-identical TRBV7-8/TRAV26 expansion. In addition, the clonal donor 2 EEN-specific expansion appeared to increase in frequency with time (Figure 1C). This observation in the donor, aged 61 years in 2005, is consistent with a previous study showing virus-specific CTLs sometimes increasing with age.11



View larger version (23K):
[in this window]
[in a new window]
 
Figure 1.. Longitudinal analysis of the EBV-specific CTL response in the peripheral blood of two healthy donors. (A) V(D)J (variable-diversity-joining) junctional TcR sequences from FLRGRAYGL-reactive CTLs from donor 1 during 1987 and 2005, including CTL cell lines generated in 1987 and ex vivo HLA B*0801-FLRGRAYGL pentamer-sorted CD8+ cells in 2005. (B) V(D)J junctional TcR sequences from EENLLDFVRF-reactive CTLs from donor 2 during 1994 and 2005, including CTL cell lines generated in 1994 and ex vivo HLA B*4405-EENLLDFVRF tetramer-sorted CD8+ cells from 1994 and 2005. The TcR extraction procedure from CTL cell lines or pentamer/tetramer-sorted cells was performed as previously described.6,8 TcR germline sequences are underlined and TcR gene designations follow the nomenclature of the International ImMunoGeneTics Information System.9 (C) HLA B*4405-EENLLDFVRF tetramer-reactive T cells from donor 2 at the time points 1994 and 2005. Peripheral blood mononuclear cells (PBMCs) were stained with tetramer and anti-CD8 monoclonal antibody (mAb). The numbers in the right upper quadrants signify the frequency of CD8high cells that stained with tetramer. We sorted the tetramer-positive cells by fluorescence-activated cell sorting and performed a switch mechanism at the 5' end of the RNA transcript (SMART) rapid amplification of complementary DNA ends (RACE) anchor polymerase chain reaction (PCR; Clontech, Mountain View, CA) on the extracted RNA. f values signify the frequency of TcR recovered from either CTL cell lines or multimer-sorted CD8+ T cells.

 
This study follows the CTL response toward two immunodominant class I-binding EBV epitopes over a period of 18 or 11 years. Remarkably, we found no evidence of perturbations in the T-cell hierarchy over time, with both clonal CTL expansions remaining unchanged. Overall, the study provides an important advance in understanding the longevity and stability of the T-cell repertoire toward a persistent pathogen. Indeed, these findings suggest the likely situation of a single naive T-cell expansion facilitating the control of a persistent viral infection for the entire span of a human life.

John J. Miles, Sharon L. Silins, Andrew G. Brooks, Joanne E. Davis, Ihor Misko, and Scott R. Burrows

Correspondence: Scott Burrows, Queensland Institute of Medical Research, Brisbane, Australia; e-mail: scott.burrows{at}qimr.edu.au.

References

  1. Silins SL, Cross SM, Elliott SL, et al. Development of Epstein-Barr virus-specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med. 1996;184: 1815-1824.[Abstract/Free Full Text]

  2. Silins SL, Sherritt MA, Silleri JM, et al. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood. 2001;98: 3739-3744.[Abstract/Free Full Text]

  3. Annels NE, Callan MF, Tan L, Rickinson AB. Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J Immunol. 2000;165: 4831-4841.[Abstract/Free Full Text]

  4. Bharadwaj M, Burrows SR, Burrows JM, Moss DJ, Catalina M, Khanna R. Longitudinal dynamics of antigen-specific CD8+ cytotoxic T lymphocytes following primary Epstein-Barr virus infection. Blood. 2001;98: 2588-2589.[Free Full Text]

  5. Argaet VP, Schmidt CW, Burrows SR, et al. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus. J Exp Med. 1994;180: 2335-2340.[Abstract/Free Full Text]

  6. Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection. J Clin Invest. 1998;102: 1551-1558.[Medline] [Order article via Infotrieve]

  7. Kjer-Nielsen L, Clements CS, Purcell AW, et al. A structural basis for the selection of dominant alphabeta T cell receptors in antiviral immunity. Immunity. 2003;18: 53-64.[CrossRef][Medline] [Order article via Infotrieve]

  8. Borg NA, Ely LK, Beddoe T, et al. The CDR3 regions of an immunodominant T cell receptor dictate the `energetic landscape' of peptide-MHC recognition. Nat Immunol. 2005;6: 171-180.[CrossRef][Medline] [Order article via Infotrieve]

  9. IMGT: International ImMunoGeneTics information system. http://imgt.cines.fr/. Accessed March 4, 2005.

  10. Khanna R, Burrows SR, Moss DJ. Immune regulation in Epstein-Barr virus-associated diseases. Microbiol Rev. 1995;59: 387-405.[Abstract/Free Full Text]

  11. Khan N, Shariff N, Cobbold M, et al. Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002;169: 1984-1992.[Abstract/Free Full Text]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
E. M. Iancu, P. Corthesy, P. Baumgaertner, E. Devevre, V. Voelter, P. Romero, D. E. Speiser, and N. Rufer
Clonotype Selection and Composition of Human CD8 T Cells Specific for Persistent Herpes Viruses Varies with Differentiation but Is Stable Over Time
J. Immunol., July 1, 2009; 183(1): 319 - 331.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. K. Archbold, W. A. Macdonald, S. Gras, L. K. Ely, J. J. Miles, M. J. Bell, R. M. Brennan, T. Beddoe, M. C.J. Wilce, C. S. Clements, et al.
Natural micropolymorphism in human leukocyte antigens provides a basis for genetic control of antigen recognition
J. Exp. Med., January 16, 2009; 206(1): 209 - 219.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Venturi, H. Y. Chin, T. E. Asher, K. Ladell, P. Scheinberg, E. Bornstein, D. van Bockel, A. D. Kelleher, D. C. Douek, D. A. Price, et al.
TCR {beta}-Chain Sharing in Human CD8+ T Cell Responses to Cytomegalovirus and EBV
J. Immunol., December 1, 2008; 181(11): 7853 - 7862.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. A. Price, A. D. Bitmansour, J. B. Edgar, J. M. Walker, M. K. Axthelm, D. C. Douek, and L. J. Picker
Induction and Evolution of Cytomegalovirus-Specific CD4+ T Cell Clonotypes in Rhesus Macaques
J. Immunol., January 1, 2008; 180(1): 269 - 280.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miles, J. J.
Right arrow Articles by Burrows, S. R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2005 by American Society of Hematology         Online ISSN: 1528-0020